UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses

Journal of medical virology, 2020-05, Vol.92 (5), p.512-517

2020

Volltextzugriff (PDF)

Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older

The Journal of infectious diseases, 2009-07, Vol.200 (2), p.172-180

2009

Volltextzugriff (PDF)

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-09, Vol.322 (9), p.824

2019

Volltextzugriff (PDF)

A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system

Vaccine, 2022-02, Vol.40 (9), p.1271-1281

2022

Volltextzugriff (PDF)

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

Clinical and Vaccine Immunology, 2010-12, Vol.17 (12), p.1875-1880

2010

Volltextzugriff (PDF)

MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly

Vaccine, 2022-03, Vol.40 (10), p.1472-1482

2022

Volltextzugriff (PDF)

Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel

The Journal of infectious diseases, 2022-03, Vol.225 (5), p.891-902

2022

Volltextzugriff (PDF)

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

Vaccine, 2014-05, Vol.32 (21), p.2507-2517

2014

Volltextzugriff (PDF)

Interpatient mutational spectrum of human coronavirus‐OC43 revealed by illumina sequencing

Journal of medical virology, 2017-08, Vol.89 (8), p.1330-1338

2017

Volltextzugriff (PDF)

Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease

The Journal of infectious diseases, 2009-03, Vol.199 (6), p.847-857

2009

Volltextzugriff (PDF)

Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e4428-e4432

2021

Volltextzugriff (PDF)

Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults

Vaccine, 2015-02, Vol.33 (9), p.1151-1159

2015

Volltextzugriff (PDF)

Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults

The American journal of medicine, 2015-11, Vol.128 (11), p.1251.e11-1251.e20

2015

Volltextzugriff (PDF)

Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons

Infection control and hospital epidemiology, 2018-04, Vol.39 (4), p.452-461

2018

Volltextzugriff (PDF)

Impact of mandatory vaccination of healthcare personnel on rates of influenza and other viral respiratory pathogens

Infection control and hospital epidemiology, 2022-09, Vol.43 (9), p.1216-1220

2022

Volltextzugriff (PDF)

Take-home kits to detect respiratory viruses among healthcare personnel: Lessons learned from a cluster randomized clinical trial

American journal of infection control, 2021-07, Vol.49 (7), p.893-899

2021

Volltextzugriff (PDF)

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age

Vaccine, 2013-12, Vol.31 (50), p.6034-6040

2013

Volltextzugriff (PDF)

Outpatient healthcare personnel knowledge and attitudes towards infection prevention measures for protection from respiratory infections

American journal of infection control, 2021-11, Vol.49 (11), p.1369-1375

2021

Volltextzugriff (PDF)

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

The Journal of infectious diseases, 2008-11, Vol.198 (9), p.1317-1326

2008

Volltextzugriff (PDF)

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age

Vaccine, 2013-05, Vol.31 (19), p.2358-2365

2013

Volltextzugriff (PDF)

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

BMC infectious diseases, 2016-06, Vol.16 (1), p.243-243, Article 243

2016

Volltextzugriff (PDF)

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial

Vaccine, 2006-08, Vol.24 (33), p.5950-5959

2006

Volltextzugriff (PDF)

Preschool-Aged Household Contacts as a Risk Factor for Viral Respiratory Infections in Healthcare Personnel

Open forum infectious diseases, 2023-02, Vol.10 (2), p.ofad057-ofad057

2023

Volltextzugriff (PDF)

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

JAMA : the journal of the American Medical Association, 1999-07, Vol.282 (2), p.137

1999

Volltextzugriff (PDF)

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

The Journal of infectious diseases, 2001-05, Vol.183 (9), p.1343-1352

2001

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(118)
Mit Volltextzugriff
(104)

Publikationsform

Artikel
(131)

Sprache

Englisch
(131)

Erscheinungsjahr

n.n

Thema

Science & Technology
(81)
Life Sciences & Biomedicine
(80)
Biological And Medical Sciences
(60)
Humans
(60)
Infectious Diseases
(58)
Immunology
(56)
Microbiology
(51)
Medical Sciences
(41)
Male
(38)
Fundamental And Applied Biological Sciences. Psychology
(36)
Virology
(35)
Female
(33)
Vaccines, Antisera, Therapeutical Immunoglobulins And Monoclonal Antibodies
(32)
Adult
(29)
Middle Aged
(29)
Vaccination
(29)
Antibodies
(27)
Viruses
(25)
Human Immunodeficiency Virus 1
(23)
Vaccines
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses

Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older

N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel: A Randomized Clinical Trial

A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system

Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum

MAS-1, a novel water-in-oil adjuvant/delivery system, with reduced seasonal influenza vaccine hemagglutinin dose may enhance potency, durability and cross-reactivity of antibody responses in the elderly

Influence of Preseason Antibodies Against Influenza Virus on Risk of Influenza Infection Among Healthcare Personnel

Immunogenicity and safety of Fluzone® intradermal and high-dose influenza vaccines in older adults ≥65 years of age: A randomized, controlled, phase II trial

Interpatient mutational spectrum of human coronavirus‐OC43 revealed by illumina sequencing

Human Coronavirus and Acute Respiratory Illness in Older Adults with Chronic Obstructive Pulmonary Disease

Risk Factors for Healthcare Personnel Infection With Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT)

Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults

Coronavirus and Other Respiratory Illnesses Comparing Older with Young Adults

Protecting Healthcare Personnel in Outpatient Settings: The Influence of Mandatory Versus Nonmandatory Influenza Vaccination Policies on Workplace Absenteeism During Multiple Respiratory Virus Seasons

Impact of mandatory vaccination of healthcare personnel on rates of influenza and other viral respiratory pathogens

Take-home kits to detect respiratory viruses among healthcare personnel: Lessons learned from a cluster randomized clinical trial

Safety and immunogenicity of revaccination with reduced dose intradermal and standard dose intramuscular influenza vaccines in adults 18–64 years of age

Outpatient healthcare personnel knowledge and attitudes towards infection prevention measures for protection from respiratory infections

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18–64 years of age

The Respiratory Protection Effectiveness Clinical Trial (ResPECT): a cluster-randomized comparison of respirator and medical mask effectiveness against respiratory infections in healthcare personnel

Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial

Preschool-Aged Household Contacts as a Risk Factor for Viral Respiratory Infections in Healthcare Personnel

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

Safety and Immunogenicity of a Canarypox-Vectored Human Immunodeficiency Virus Type 1 Vaccine with or without gp120: A Phase 2 Study in Higher- and Lower-Risk Volunteers

Suchergebnisse filtern